Try our beta test site
2 studies found for:    19487264 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)
Condition: Osteoporosis
Intervention: Drug: MK0217/Duration of Treatment : 12 Months
2 Active, not recruiting Safety and Effectiveness of Oral Alendronate Therapy on Bone Mineral Density in HIV-infected Children and Adolescents With Low Bone Mineral Density
Condition: HIV Infections
Interventions: Drug: Alendronate;   Drug: Alendronate placebo;   Dietary Supplement: Calcium carbonate/vitamin D

Study has passed its completion date and status has not been verified in more than two years.